ArticleCellular and molecular neurobiology2026
Explainable Hybrid Deep Learning Framework Integrating MobileNetV2, EfficientNetV2B0, and KNN for MRI-Based Brain Tumor Classification.
Article in Cellular and molecular neurobiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- From voxels to models: a multi-center voxel-based morphometry study identifying robust biomarkers for deep learning classification of schizophrenia.Brain imaging and behavior · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Magnetic resonance imaging (MRI) is central to noninvasive brain tumor assessment, yet clinical uptake of artificial intelligence depends on both accuracy and transparency. This study presents a lightweight and interpretable hybrid framework that fuses features from two efficient convolutional backbones, MobileNetV2 and EfficientNetV2B0, using late fusion with global average pooling and vector concatenation. Classification is performed with a K‑Nearest Neighbors (KNN) head configured with k = 5, Euclidean distance, and distance‑based weighting. The dataset contains 7,023 MRI images drawn from Figshare, SARTAJ, and BR35H. Data were split with a 20% held‑out test set and a validation set equal to 20% of the remaining training pool, yielding 64%/16%/20% train/val/test. Four diagnostic categories were evaluated: Glioma, Meningioma, Pituitary, and Notumor. The confusion matrix shows a compact diagonal, and class‑wise precision, recall, and F1 are consistently high on the test set. A 5‑fold cross‑validation with normality assessment and paired significance testing supports robustness across folds. On the held‑out test set, class‑wise ROC-AUC was 1.00 for all four classes, and overall accuracy was 99.69%. Results should be interpreted in light of the unified dataset; external validation is warranted. Clinical interpretability is supported by class‑wise Grad‑CAM overlays and SHAP analyses, including waterfall plots that quantify individual feature contributions. These findings indicate that a dual‑backbone late‑fusion design coupled with a simple nonparametric classifier delivers strong, balanced performance while providing anatomically plausible case‑level insight into model decisions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.